FLORIDA A&M UNIVERSITY AND BRISTOL-MYERS SQUIBB PHARMACEUTICAL INDUSTRY RESIDENCY PROGRAM 2015-2016
TABLE OF CONTENTS Dear Prospective Residents......................................................... 3 About Florida A&M University....................................................... 3 About Bristol-Myers Squibb......................................................... 4 Executive Sponsor Spotlight........................................................ 4 Current Residents................................................................. 5 Residency Program Overview....................................................... 5 Two-Year Residencies Offered 2015-2016.............................................. 6 U.S. Medical Strategy, Oncology................................................... 6 Medical Information, Oncology..................................................... 6 Past Residents................................................................... 7 Application Process...................................................... Back Cover RESIDENCY SITES AND AREAS OF FOCUS Florida Agricultural And Mechanical University 10650 State Road 84 Davie, FL 33324 2 Bristol-Myers Squibb 777 Scudders Mill Road Plainsboro, NJ 08536
DEAR PROSPECTIVE RESIDENTS I would like to start by commending you on your interest in the Florida A&M University Residency in collaboration with Bristol-Myers Squibb. Although a relatively young program, this residency already has an impressive track record and network of successful alumni that continues to grow. The Florida A&M University College of Pharmacy works cooperatively with Bristol-Myers Squibb to offer this unique residency program, which creates roles for the resident as both faculty at the university and staff at the company. The goal of the program is to provide the resident with a rich experience in industry and to emphasize the importance of teaching and research. This comports with the mission of the College of Pharmacy and Pharmaceutical Sciences to prepare students for life-long learning and careers in an evolving profession of pharmacy. This must be a very exciting time for you as the culmination of your didactic training approaches and post-doctoral opportunities begin to present themselves. I want to be the first to say congratulations, wish you luck during the recruitment process, and advise you to consider this unique experience within the pharmaceutical industry. Michael D. Thompson, Pharm.D. Dean, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University FLORIDA A&M UNIVERSITY The Florida A&M University College of Pharmacy and Pharmaceutical Sciences (CoPPS) program offers Pharm.D., M.S., and Ph.D. degrees to its students. With its main campus in Tallahassee, Florida, it is the only pharmacy program in the United States that has a fully accredited Institute of Public Health both on-site and managed by the College of Pharmacy. The College has additional instructional sites in Jacksonville, Davie, Tampa and Crestview, which support the infrastructure for the College s statewide commitment to pharmacy education and public service. The evolution of the College has witnessed the initiation of pharmacy education with just one student in the beginning to now being one of the largest colleges of pharmacy in the country. Currently, the College has more than 1,000 students and faculty. COPPS has a rich history of producing high-caliber graduates capable of providing exceptional pharmaceutical care. Our unique program focuses on academic excellence, research superiority, and community service; this allows us to prepare students for leading roles in the practice of pharmacy, research and public health. The Florida A&M University College of Pharmacy and Pharmaceutical Sciences reinforces its primary mission through an active role and responsibility in the delivery, outcome, and study of pharmaceutical care services it shares with other healthcare providers. The College is committed to the advancement of pharmaceutical knowledge through teaching, research, and service in a supportive and caring environment that enhances the attainment of educational excellence and the highest standards in professional and ethical practice. 3
BRISTOL-MYERS SQUIBB Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We concentrate our research efforts in four core therapeutic areas: Cardiovascular, Immunoscience, Oncology, and Virology. At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a successful biotechnology company. Innovation is at the heart of everything we do. Innovation sparks the groundbreaking science of our laboratories, the state-of-the-art processes in our manufacturing plants, and our pioneering approach to product commercialization. We are committed to the highest standards of ethics and integrity and promoting economic, social, and environmental sustainability. At Bristol-Myers Squibb, we are passionate about science, passionate about innovation, and passionate about making a difference in the lives of patients. EXECUTIVE SPONSOR SPOTLIGHT Bristol-Myers Squibb is a great company for pharmacists entering the pharmaceutical industry. Over the many years I have been at Bristol-Myers Squibb, I have personally witnessed the value of their unique skill set, training, and experience that enables them to excel and rise to important management and leadership roles. The diversity and cohesiveness of our Pharm.D. program and our pharmacy community at Bristol-Myers Squibb provides an exceptional experience of seeing, doing, and teaching, which readily prepares our residents for future opportunities to succeed in our Medical and Commercial organizations. Patrick Reilly Residency Executive Sponsor Vice President, Worldwide Medical Information 4 As a leader at Bristol-Myers Squibb, I appreciate the importance of growing and engaging talent within Bristol-Myers Squibb in order to fulfill our mission to help patients prevail over serious diseases. Clearly the Florida A&M University Pharm.D. Residency is an important part of our talent strategy and key to building and cultivating an innovative culture at Bristol-Myers Squibb.
CURRENT RESIDENTS 2015-2016 Shanada Thomas, Pharm.D., RPh Oncology Clinical Residency - FL (1st Year) Medical Information, Oncology NJ (2nd Year) Florida A&M University Marissa West, Pharm.D., RPh Oncology Clinical Residency - FL (1st Year) U.S. Medical Strategy, Oncology NJ (2nd Year) Florida A&M University RESIDENCY PROGRAM OVERVIEW This pharmaceutical industry residency program was founded in 2009 as a partnership between Florida A&M University and Bristol-Myers Squibb. The vision of the residency is to attract and develop a diverse group of talented pharmacists who bring clinical expertise, innovative ideas, and dedication to improving patient outcomes. The program began with one resident in Medical Information. In 2011, the program expanded to include a position in R&D Strategy and Analytics in addition to the existing Medical Information role. Residents worked across all company therapeutic areas to support global initiatives and projects. The program has further evolved and now provides a two-year residency in the therapeutic area of oncology. This residency will provide the residents with a unique experience that bridges the gap between clinical practice and the pharmaceutical industry. FIRST YEAR During the first year, the residents will participate in clinical pharmacology and pharmacy practice with emphasis in hematology/oncology and transplant medicine at practice sites in South Florida and FAMU COPPS. While at the college, the residents will also participate in workshops, meetings, and other faculty related engagements to promote professional growth. Their responsibilities include: Provide pharmaceutical care and patient education within inpatient and outpatient settings Deliver lectures to student pharmacists, pharmacists, nurses, and medical residents Collaborate with preceptors to educate pharmacy students SECOND YEAR In the second year, the residents will have an opportunity to work within Medical Information or Medical Strategy at Bristol-Myers Squibb in Plainsboro, NJ. The residents of this program have varied experiences that augment their professional development. They collaborate with stakeholders across the company s targeted disease areas to help patients prevail over serious diseases. This program furthers the Bristol-Myers Squibb commitment to embrace a diverse workforce and an inclusive culture. First-Year Residency Program Director: Nathan E Eraikhuemen, Pharm.D. Associate Professor of Medicine & Pharmacy Practice Division Director of Pharmacy Practice 5
U.S. MEDICAL STRATEGY, ONCOLOGY Preceptor: Maria Moricz, Pharm.D. Associate Director, U.S. Medical Strategy, Oncology This residency provides a unique experience for individuals interested in developing their clinical and product expertise and medical communication skills within a matrix environment. The resident will have opportunities to: Represent Medical on a cross-functional matrix team that includes commercial, field medical, health economics, market access, medical information, pharmacovigilance, advocacy, and others Develop and execute clinical strategy tactics that support oncology brand and disease state initiatives Create content for medical presentations, publications, and field medical resources Communicate and collaborate with external clinical experts in scientific advisory boards and medical conferences Assist with generation of clinical trial, market research, and pharmacoeconomic data in support of the brand Provide brand and disease training to the medical matrix team, field medical, sales, and external clinicians Build networking, communication, project management, and leadership skills required for a career within the pharmaceutical industry MEDICAL INFORMATION, ONCOLOGY Second-Year Preceptor: Arlene Santhouse, Pharm.D. Director, Global Medical Contact Centers - Americas 6 Second-Year Preceptor: Lisa Patel, PharmD, MBA Associate Director, Contact Center Operations The Medical Information department is responsible for providing medical and scientific knowledge on all Bristol-Myers Squibb pharmaceutical products. The resident will learn the key functions of the Medical Information department by applying clinical pharmacy knowledge to ensure accurate communication of product information. As part of this program, the resident will gain numerous development opportunities. Provide medically accurate responses to medical information inquiries from patients and healthcare professionals Create, update, and customize standard responses for a global database Identify and report adverse events and product quality complaints Participate in the medical review of promotional and nonpromotional materials with matrix team members (e.g., Marketing, Legal, and Regulatory) Conduct research to be presented at a national professional meeting Make key contributions to projects and presentations as dictated by business needs
PAST RESIDENTS Tope Osiyemi, Pharm.D. Worldwide Medical Content-Oncology, Medical Writer, Bristol-Myers Squibb Medical Information Resident, 2014-2015 The Post-doctoral residency has provided an enriching experience for me as a pharmacist within the pharmaceutical industry. During my time as a resident at Bristol-Myers Squibb, I have been able to gain hands on experience across matrix teams, fostered by an in-depth understanding of the framework of the medical organization, establish relationships and collaborate with amazing colleagues throughout the organization, meet senior executives and stakeholders within the company, as well as opportunities to work on high-impact projects that bring value to the business. My preceptors, mentors and colleagues here at Bristol-Myers Squibb have been instrumental in my professional development and such a foundation has been insurmountable to being successful in my role with the Worldwide Team. Jade Hoang, Pharm.D. HIV Medical Scientist, Bristol-Myers Squibb R&D Strategy and Analytics Resident, 2014-2015 The time spent at Bristol-Myers Squibb has been an amazing experience. I had opportunities to work on exciting projects with incredible colleagues and learn from them. The friendships, mentors, and network I ve established here will continue to help me throughout my personal and professional life. The transferrable skills acquired in R&D Strategy and Analytics together with my PharmD training have provided a solid foundation to start my career in the pharmaceutical industry as a Medical Affairs professional. Ijeoma Nwosu, Pharm.D. Manager, Medical Information-Oncology, Bristol-Myers Squibb Medical Information Resident, 2013-2014 Karina Utkina, Pharm.D. Medical Science Liaison, Companion Dx Reference Lab, LLC R&D Strategy and Analytics Resident, 2013-2014 Dawn Bey,Pharm.D. Medical Science Liaison, Immuno-Oncology, Lung/Melanoma, Bristol-Myers Squibb R&D Strategy and Analytics Resident, 2012-2013 Olakiitan Babalola, Pharm.D. Medical Information Manager, Myeloid/Lymphoma, Celgene Corporation Medical Information Resident, 2012-2013 Lina Morton, Pharm.D. Oncology EMAC & IC Publications Lead, Bristol-Myers Squibb Medical Information Resident, 2009-2010 Christina Wright, Pharm.D. Medical Science Liaison, Metabolics, AstraZeneca Medical Information Resident, 2011-2012 7
APPLICATION PROCESS Application Materials Due Friday, December 18th, 2015 QUALIFICATIONS: Required: Doctor of Pharmacy (Pharm.D.) degree from an accredited institution prior to the start of the residency Preferred: Participation in the ASHP Midyear Clinical Meeting PPS APPLICATION MATERIALS: Letter of Intent Curriculum vitae Three letters of recommendation SUBMISSION: Please EMAIL all materials to drug.information@bms.com Subject: FAMU Residency Program PROCESS: Select candidates will be contacted for an onsite interview One candidate will be selected for each position All candidates will be notified of their status by the end of February 2015 Bristol-Myers Squibb Company, Princeton, NJ 08543 Printed on paper containing 20% post-consumer waste. NOUS1502487-01-01 10/2015